Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v1-EN
Language French English
Date Updated 2022-12-01 2021-12-14
Drug Identification Number 02347253 02347253
Brand name AURO-CEFPROZIL AURO-CEFPROZIL
Common or Proper name CEFPROZIL CEFPROZIL
Company Name AURO PHARMA INC AURO PHARMA INC
Ingredients CEFPROZIL CEFPROZIL
Strength(s) 500MG 500MG
Dosage form(s) TABLET TABLET TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100's 100's
ATC code J01DC J01DC
ATC description OTHER BETA-LACTAM ANTIBACTERIALS OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2021-12-13 2021-12-13
Estimated end date 2022-11-30 2022-05-21
Actual end date 2022-11-25
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments